Microfluidics in Cancer therapy

FOR IMMEDIATE RELEASE

Global Cutting-Edge Study Unveils Microfluidic Device for Precision Cancer Therapy

Toronto, ON – Groundbreaking research conducted by a team of scientists from the University of Toronto, Iran, Italy, and Finland has brought forth a pioneering advancement in the field of cancer treatment. The study, titled "Fabrication of a Microfluidic Device for Probiotic Drug’s Dosage Screening: Precision Medicine for Breast Cancer Treatment," has been published in the esteemed journal, Translational Oncology.

Breast cancer, a prevalent malignancy affecting millions of women worldwide, has long required innovative approaches for effective treatment. This study introduces a novel microfluidic device that leverages the dynamic cell culture conditions to assess the anti-cancer activities of probiotic strains against MCF-7 breast cancer cells. The research emphasizes the potential of probiotics in cancer therapy, highlighting their ability to induce apoptosis and combat cancer cells effectively.

The microfluidic device, a product of sophisticated design and fabrication, enables the creation of concentration gradients of probiotics, allowing for the precise determination of the most effective dosages against breast cancer cells. This innovative approach to drug dosage screening marks a significant departure from traditional methods, offering a more personalized and effective treatment strategy.

Dr. Masoud Akhshik, a prominent figure in the research team, commented on the breakthrough, stating, "This research is not just a step forward in breast cancer treatment; it's a leap towards personalized and precise medicine. By harnessing the power of microfluidics and the natural potency of probiotics, we're opening new doors to combat cancer more effectively and with fewer side effects."

The study's results are promising, demonstrating that microfluidic devices can offer a more sensitive and accurate analysis compared to conventional methods. This precision paves the way for personalized medicine, ensuring that patients receive the most effective treatment tailored to their specific needs.

This research was made possible through the collaborative efforts of esteemed scientists from different institutes and universities around the world. Their dedication and innovative approach to cancer therapy have set new standards in the field of medical research.

For more information about this groundbreaking study and its profound implications for the future of cancer treatment, the full paper is available in the journal Translational Oncology.

-END-